-
-
-
-
-
-
-
Helius Medical Technologies, Inc. Announces FDA Breakthrough Device Designation for the Treatment of Dynamic Gait and Balance Deficits Following a Stroke
-
-
-
-
-
-
-
Helius Medical Technologies, Inc. to Participate in the Annual World Congress of the Society for Brain Mapping and Therapeutics
-
-
-
-
-
-
-
Helius Medical Technologies, Inc. to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021
-
-
-
-
-
-
-
Helius Medical Technologies, Inc. Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
-
-
-
-
-
-
-
Helius Medical Technologies, Inc. to Present atĀ Four Upcoming Investor Conferences in January
-
-
-
-
-
-
-
Helius Medical Technologies Announces Closing of $3.4 Million Private Placement
-
-
-
-
-
-
-
Helius Medical Technologies, Inc. Announces Departure of President, Chief Executive Officer and Chairman Philippe Deschamps; Board of Directors Appoints Dane C. Andreeff as Interim President and Chief
-
1,157,877 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

